Latest Articles

The ink is barely dry on the New Jersey ATC and Missouri medical marijuana facility applications that so many of us assembled this August. Yet now, a new round of states have issued applications for competitive cannabis licenses. Below we discuss the qualifications, requirements, deadlines and other relevant information for the Illinois (adult use), Michigan (adult use) and Texas (medical; <.5% THC) applications. Foley Hoag has significant experience preparing winning applications in markets with competitive…
The Massachusetts Department of Agricultural Resources (“MDAR”) and the state’s Department of Health (“DPH”) have issued new guidance on the sale of Hemp and Hemp-derived cannabanoids, (namely, CBD) products in Massachusetts. The MDAR guidance applies to hemp and hemp-derived products.  It establishes that the follow hemp-derived products can be sold in Massachusetts: Hemp seed Hemp seed oil Hulled hemp Hemp seed powder Hemp protein Clothing Building material Items made from hemp fiber. For these products,…
There is no business quite like cannabis, and very few that need constant attention to regulatory compliance in every aspect of operations. Friend of the blog and Director of Legal Compliance at Acreage Holdings, Gary Kaminsky, penned an excellent column recently for Law360 suggesting cannabis companies should implement regulatory Enterprise Risk Management (“ERM”) principles. The column can be found here: A Holistic Approach To Compliance For Cannabis Cos. – Law360. It’s an important read…
Last week, the CCC released two new sets of draft medical marijuana regulations so that final regulations can be promulgated in enough time for it to take over the Commonwealth’s Medical Marijuana Program by the end of the year. The CCC released a draft of 935 CMR 501, which it calls a “lift and replace” of the existing Department of Public Health medical marijuana regulations. The regulations are functionally identical, and notably still require…